Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 6 , ISSUE 1 ( January-June, 2016 ) > List of Articles

MINI REVIEW

Hepatitis in Malaysia: Past, Present, and Future

Citation Information : Hepatitis in Malaysia: Past, Present, and Future. Euroasian J Hepatogastroenterol 2016; 6 (1):52-55.

DOI: 10.5005/jp-journals-10018-1167

License: CC BY-NC 4.0

Published Online: 01-01-2016


Abstract

Malaysia is multiethnic, with a population of 31,127,247 comprising a mixture of Malays (50.1%), Chinese (22.6%), Indians (6.7%), Aborigines (11.8%), others (0.7%), and noncitizens (8.2%). Like other countries in the region, viral hepatitis is an important public health problem in Malaysia. The 3 most common causes for hepatitis in Malaysia are hepatitis A, B, and C. Hepatitis A has been a reportable disease in Malaysia since 1988. Due to the introduction of government control programs, the national incidence rate has dropped steadily. It is now estimated that 50% of Malaysians less than 30 years of age do not have antibodies to hepatitis A and are therefore susceptible to the disease, which can be prevented by reinforcing the hygiene status of the general population. Malaysia is a country of medium seroprevalence for the hepatitis B virus (HBV) surface antigen (HBsAg) in the general population (1.5–9.8%). The major route of transmission is from infected mother to fetus. There are an estimated 1 million people chronically infected with hepatitis B in Malaysia. Approximately 75% of all viral hepatitis cases are due to hepatitis B infection, with a male-to-female ratio of 2:1. Chronic hepatitis B (CHB) accounts for more than 80% of the hepatocellular carcinoma (HCC) cases seen in Malaysia and HCC is the 3rd most common malignant neoplasm and among the 10 leading causes of death. Most common genotypes are B and C. Incidence rates among Chinese, Malays, and Indians are 36, 26, and 15% respectively. The hepatitis B vaccination program for children was introduced in 1989, which successfully managed to reduce the seroprevalence of infection among Malaysians to 0.01% (graph 4, 2014). But the disease burden will still remain high for some time as the infected people are getting older and living longer. Hepatitis C virus (HCV) infection is a growing problem in Malaysia. An estimated 453,700 people were living with HCV infection in Malaysia in 2009 (2.5% of the population aged 15–64 years), of whom 59% acquired their infection through injection and the most common genotypes found are genotype 3 and 1. The HCV-related disease burden is already high and is forecast to rise steeply over the coming decades under current levels of antiviral treatment. Increased governmental resources to improve HCV screening and treatment rates and to reduce transmission are essential to address the high projected HCV disease burden in Malaysia.


PDF Share
  1. Khairullah NS, Merican DI. Hepatitis disease management programs in Malaysia. J Gastroenterol Hepat 2004 Mar;19 Graph 4: Hepatitis C virus seroprevalence from 1990 to 2014 (Suppl):S13-S16. Hepatitis in Malaysia: Past, Present, and Future Euroasian Journal of Hepato-Gastroenterology, January-June 2016;6(1):52-55 55 EJOHG 2. Health Fact 2014 – Ministry of health Malaysia. (accessed: 23/05/2016). Available from line:http://www.moh.gov.my/ images/gallery/publications/HEALTH%20FACTS%202014. pdf 3. Saat Z, Sinniah M, Kin TL, Baharuddin R, Krishnasamy M A 4 year review of acute viral hepatitis cases in the east coast of peninsular Malaysia (1994–1997). Southeast Asian J Trop Med Public Health 1999 Mar;30(1):106-109
  2. Prevalence of hepatitis A virus infection in normal individuals and hospital patients in Kuala Lumpur. Med J Malaysia 1983 Dec;38(4):279-281
  3. Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia. World J Gastroenterol 2011 Sep 28;17(36):4130-4134
  4. Chronic hepatitis B infection in Malaysians. Malays J Pathol 1994 Jun;16(1):3-6
  5. Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia. Singapore Med J 2013 Apr;54(4): 224-226
  6. Hepatitis B seroprevalence among University of Malaya Students in the Post-universal Infant Vaccination Era. Med J Malaysia 2013 Apr;68(2): 144-147
  7. Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis. BMC Infect Dis 2014 Nov7;14:564
  8. Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre. Pakistan J Med Sci 2013 Sep;29(5):1142-1146
  9. Hepatitis C – the Malaysian story. Singapore Med J 1993 Apr;34(2):132-134
  10. Projections of the current and future disease burden of hepatitis C virus infection in Malaysia. PLoS One 2015 Jun 4;10(6):e0128091.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.